Plaque Psoriasis Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Plaque Psoriasis Treatment Market By Product Type (Interleukin Inhibitors, Tumour Necrosis Factor (TNF), and Others), By Route of Administration (Topical, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Plaque Psoriasis Treatment Market size is valued at USD 18.0 billion in 2021 and is poised to grow at a significant CAGR of 10.0% over 2022–2028. As the prevalence of psoriasis rises worldwide, manufacturers are transforming breakthrough research into novel therapies by investing more in research. The number of medications approved for plaque psoriasis is constantly expanding, giving physicians and patients more treatment options. For instance, the FDA approved Eli Lilly’s interleukin inhibitor, the second chemical after Novartis’ Cosentyx. Companies are conducting various clinical trials and head-on-head trials with existing medications to create biologic therapies that will provide improved therapy alternatives for psoriasis patients. To encourage the acceptance of their breakthrough treatments, companies are increasingly offering co-pay choices to patients. According to the World Psoriasis Day consortium, psoriasis affects 125 million individuals worldwide. Novel systemic therapies using a variety of biologics are now being introduced. For instance, In April 2019, Ortho Dermatologics stated that an FDA-approved lotion for the treatment of psoriasis patients had been approved. The use of ‘Duobrii’ to treat plaque psoriasis has been authorized. Adults with plaque psoriasis will benefit from the product. In tandem with Duobrii to treat other significant psoriasis disorders, several efforts are being made to develop new products. The primary focus of the companies is on EU-5 and US countries to market the drugs. However, psoriasis incidence is higher in European countries like Netherlands, Norway, Denmark, and Austria and in Asia Pacific countries like China, Japan, and India. The expansion of the marketing of psoriasis drugs in these countries might provide an opportunity for the manufacturers to generate additional revenues. Celgene’s Otezla was launched in Germany, Switzerland, Austria, Scotland, and certain Scandinavian countries; the growth is expected from the expansion of the launch of OTEZLA in Europe and Japan markets, where it is well-positioned to repeat the success that is realized in the U.S. market. In October 2021, Sun Pharmaceutical Industries Ltd. announced the availability of ILUMYA in Canada to treat moderate-to-severe plaque psoriasis to strengthen its presence in Canada.

Plaque Psoriasis Treatment Market

MARKET SUMMARY
-
10.0% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 10.0%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Plaque Psoriasis Treatment Market

  • The global plaque psoriasis treatment market report gives comprehensive outlook on Plaque Psoriasis Treatment Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global plaque psoriasis treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Novartis AG (Switzerland)
  • AbbVie Inc.(U.S)
  • Amgen, Inc. (U.S)
  • Johnson & Johnson (U.S)
  • Eli Lilly and Company (U.S)
Plaque Psoriasis Treatment Market

Dynamics

The increasing prevalence of psoriasis conditions globally is projected to drive the sales of psoriasis drugs over the forecast period. Furthermore, an increase in awareness about the psoriasis conditions and active participation of non-profit organizations to bring awareness among psoriasis patients about the new therapies are expected to drive the plaque psoriasis market. On the other hand, the primary factor restraining the growth of the psoriasis market is the high cost of the drugs. Due to the drug’s higher price, the drugs are not affordable for all patients, and it has had a negative impact on the sales of the psoriasis drug market.


North-America got significant share

Plaque Psoriasis Treatment Market

The plaque psoriasis treatment market in North America is likely to hold the highest revenue share in 2022, and, in the following years, it is predicted to increase rapidly. The rising prevalence of plaque psoriasis in the United States and a strong medication pipeline are expected to boost the market in North America over the forecast period. According to the National Psoriasis Foundation, psoriasis affects about 7.4 million people in the United States, with the most common form being plaque psoriasis. The regional market will benefit from the increased demand for novel treatment options for the disease. The European plaque psoriasis treatment market is expected to grow at 11% over the forecast period. Favorable reimbursement policies are driving the region's improved market access.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

Plaque Psoriasis Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

Plaque Psoriasis Treatment Market

  1. Executive Summary
  2. Global Plaque Psoriasis Treatment Market Introduction

2.1. Global Plaque Psoriasis  Treatment Market – Taxonomy

  1. Global Plaque Psoriasis Treatment Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Plaque Psoriasis  Treatment Market Dynamic Factors – Impact Analysis

3.6. Commercial Investments of Major Brands

3.7. Drug Development Programs of Major Brands

  1. Global Plaque Psoriasis Treatment Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023

4.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market, By Product Type, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1. Interleukin Inhibitors

5.1.1. Tildrakizumab

5.1.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Guselkumab

5.1.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3. Market Opportunity Analysis

5.1.3. Ixekizumab

5.1.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3.3. Market Opportunity Analysis

5.1.4. Secukinumab

5.1.4.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.4.3. Market Opportunity Analysis

5.1.5. Ustekinumab

5.1.5.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.5.3. Market Opportunity Analysis

5.1.6. Brodalumab

5.1.6.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.6.3. Market Opportunity Analysis

5.2. Tumor Necrosis Factor (TNF) Inhibitors

5.2.1. Etanercept

5.2.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.1.3. Market Opportunity Analysis

5.2.2. Adalimumab

5.2.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.2.3. Market Opportunity Analysis

5.2.3. Infliximab

5.2.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3.3. Market Opportunity Analysis

5.3. Others

5.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market Forecast, By Route of Administration, 2015 – 2017and Forecast, 2018 – 2023

6.1. Topical

6.1.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Parenteral

6.2.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Others

6.3.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market Forecast, By Distribution Channel, 2015 – 2017and Forecast, 2018 – 2023

7.1. Hospital  Pharmacies

7.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Retail Pharmacies

7.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market Forecast, By Region, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.1. North America

8.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. RoW

8.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Global Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Region, 2018 – 2023

  1. North America Plaque Psoriasis Treatment Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

9.1. Product Type Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Interleukin Inhibitors

9.1.1.1. Tildrakizumab

9.1.1.2. Guselkumab

9.1.1.3. Ixekizumab

9.1.1.4. Secukinumab

9.1.1.5. Ustekinumab

9.1.1.6. Brodalumab

9.1.2. Tumor Necrosis Factor (TNF) Inhibitors

9.1.2.1. Etanercept

9.1.2.2. Adalimumab

9.1.2.3. Infliximab

9.1.3. Others

9.2. Route of Administration Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Topical

9.2.2. Parenteral

9.2.3. Others

9.3. Distribution Channel Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Others

9.4. Country Analysis 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023

  1. Europe Plaque Psoriasis Treatment Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

10.1. Product Type Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Interleukin Inhibitors

10.1.1.1. Tildrakizumab

10.1.1.2. Guselkumab

10.1.1.3. Ixekizumab

10.1.1.4. Secukinumab

10.1.1.5. Ustekinumab

10.1.1.6. Brodalumab

10.1.2. Tumor Necrosis Factor (TNF) Inhibitors

10.1.2.1. Etanercept

10.1.2.2. Adalimumab

10.1.2.3. Infliximab

10.1.3. Others

10.2. Route of Administration Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Topical

10.2.2. Parenteral

10.2.3. Others

10.3. Distribution Channel Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Others

10.4. Country Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Germany

10.4.2. UK

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023

  1. RoW Plaque Psoriasis Treatment Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

11.1. Product Type Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Interleukin Inhibitors

11.1.1.1. Tildrakizumab

11.1.1.2. Guselkumab

11.1.1.3. Ixekizumab

11.1.1.4. Secukinumab

11.1.1.5. Ustekinumab

11.1.2. Tumor Necrosis Factor (TNF) Inhibitors

11.1.2.1. Adalimumab

11.1.2.2. Infliximab

11.1.3. Others

11.2. Route of Administration Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Topical

11.2.2. Parenteral

11.2.3. Others

11.3. Distribution Channel Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Others

11.4. Country Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. Brazil

11.4.5. Others

11.5. Asia-Pacific Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023

  1. Competition Landscape

12.1. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

12.1.1. Novartis AG

12.1.2. AbbVie Inc.

12.1.3. Amgen, Inc

12.1.4. Johnson & Johnson

12.1.5. Eli Lilly and Company

12.1.6. Celgene Corporation

12.1.7. Sun Pharmaceuticals Industries Ltd.

  1. Research Methodology
  2. Key Assumptions and Acronyms

Figure 01: Global Plaque Psoriasis Treatment Market Revenue Share (%), by Product Type (2017)

Figure 02: Global Plaque Psoriasis Treatment Market Revenue Share (%), by Route of Administration (2017)

Figure 03: Global Plaque Psoriasis Treatment Market Revenue (US$ Mn), by Distribution Channel (2015, 2017, and 2023)

Figure 04: Global Plaque Psoriasis Treatment Market Revenue Share (%) by Region (2017)

Figure 05: Global Plaque Psoriasis Treatment Market – Regional Revenue Hotspots (2017)

Figure 06: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2015-2023

Figure 07: Global Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2015, 2017, & 2023

Figure 08: Global Plaque Psoriasis Treatment Market Share (%), By Product Type 2018 & 2023

Figure 09: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Product Type, 2018 – 2023

Figure 10: Global  Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Interleukin Inhibitors 2015-2023

Figure 11: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Tumor Necrosis Factor (TNF) 2015-2023

Figure 12: Global  Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Others 2015-2023

Figure 13: Global Plaque Psoriasis Treatment Market Share (%), By Route of Administration 2018 & 2023

Figure 14: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Route of Administration , 2018 – 2023

Figure 15: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Topical administration, 2012-2023

Figure 16: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Parenteral administration, 2012-2023

Figure 17: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Others, 2012-2023

Figure 18: Global Plaque Psoriasis Treatment Market Share (%), By Distribution Channel, 2018 & 2023

Figure 19: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), By Distribution Channel, 2018 – 2023

Figure 20: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Hospital Pharmacies, 2012-2023

Figure 21: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Retail Pharmacies, 2012-2023

Figure 22: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn, By Others, 2012-2023

Figure 23: Global Plaque Psoriasis Treatment Market Share (%), By Region, 2018 & 2023

Figure 24: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Region, 2018 – 2023

Figure 25: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023

Figure 26: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023

Figure 27: Rest of the world Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023

Figure 28: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 29: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 30: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 31: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Figure 32: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023

Figure 33: North America Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023

Figure 34: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017

Figure 35: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017

Figure 36: North America Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017

Figure 37: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017

Figure 38: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 39: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 40: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 41: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Figure 42: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023

Figure 43: Europe Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023

Figure 44: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017

Figure 45: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017

Figure 46: Europe Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017

Figure 47: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017

Figure 48: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 49: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 50: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 51: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Figure 52: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023

Figure 53: RoW Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023

Figure 54: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017

Figure 55: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017

Figure 56: RoW Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017

Figure 57: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017

Figure 58: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 59: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 60: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 61: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Table 01: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 02: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 03: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023

Table 04: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Region, 2012-2023

Table 05: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023

Table 06: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 07: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 08: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023

Table 09: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023

Table 10: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 11: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 12: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023

Table 13: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023

Table 14: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 15: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 16: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023


Report

Company Profile

  • Allergan
  • Johnson and Johnson
  • Amgen
  • Abbvie
  • Eli Lilly
  • Dermira Inc.
  • Novartis
  • Galectin Therapeutics
  • Cellceutix Corporation
  • Biogen Inc.
  • Bayer AG

Description

Plaque Psoriasis Treatment Market size is valued at USD 18.0 billion in 2021 and is poised to grow at a significant CAGR of 10.0% over 2022–2028. As the prevalence of psoriasis rises worldwide, manufacturers are transforming breakthrough research into novel therapies by investing more in research. The number of medications approved for plaque psoriasis is constantly expanding, giving physicians and patients more treatment options. For instance, the FDA approved Eli Lilly’s interleukin inhibitor, the second chemical after Novartis’ Cosentyx. Companies are conducting various clinical trials and head-on-head trials with existing medications to create biologic therapies that will provide improved therapy alternatives for psoriasis patients. To encourage the acceptance of their breakthrough treatments, companies are increasingly offering co-pay choices to patients. According to the World Psoriasis Day consortium, psoriasis affects 125 million individuals worldwide. Novel systemic therapies using a variety of biologics are now being introduced. For instance, In April 2019, Ortho Dermatologics stated that an FDA-approved lotion for the treatment of psoriasis patients had been approved. The use of ‘Duobrii’ to treat plaque psoriasis has been authorized. Adults with plaque psoriasis will benefit from the product. In tandem with Duobrii to treat other significant psoriasis disorders, several efforts are being made to develop new products. The primary focus of the companies is on EU-5 and US countries to market the drugs. However, psoriasis incidence is higher in European countries like Netherlands, Norway, Denmark, and Austria and in Asia Pacific countries like China, Japan, and India. The expansion of the marketing of psoriasis drugs in these countries might provide an opportunity for the manufacturers to generate additional revenues. Celgene’s Otezla was launched in Germany, Switzerland, Austria, Scotland, and certain Scandinavian countries; the growth is expected from the expansion of the launch of OTEZLA in Europe and Japan markets, where it is well-positioned to repeat the success that is realized in the U.S. market. In October 2021, Sun Pharmaceutical Industries Ltd. announced the availability of ILUMYA in Canada to treat moderate-to-severe plaque psoriasis to strengthen its presence in Canada.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX